233 related articles for article (PubMed ID: 20131980)
1. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis.
Poulin Y; Papp K; Bissonnette R; Barber K; Kerrouche N; Villemagne H;
J Dermatolog Treat; 2010 May; 21(3):185-92. PubMed ID: 20131980
[TBL] [Abstract][Full Text] [Related]
2. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.
Poulin Y; Papp K; Bissonnette R; Guenther L; Tan J; Lynde C; Kerrouche N; Villemagne H;
Cutis; 2010 Jan; 85(1):43-50. PubMed ID: 20184211
[TBL] [Abstract][Full Text] [Related]
3. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
Andres P; Poncet M; Farzaneh S; Soto P
J Drugs Dermatol; 2006 Apr; 5(4):328-32. PubMed ID: 16673799
[TBL] [Abstract][Full Text] [Related]
4. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
[TBL] [Abstract][Full Text] [Related]
5. A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis.
Griffiths CE; Finlay AY; Fleming CJ; Barker JN; Mizzi F; Arsonnaud S
J Dermatolog Treat; 2006; 17(2):90-5. PubMed ID: 16766333
[TBL] [Abstract][Full Text] [Related]
6. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.
Reygagne P; Mrowietz U; Decroix J; de Waard-van der Spek FB; Acebes LO; Figueiredo A; Caputo R; Poncet M; Arsonnaud S
J Dermatolog Treat; 2005 Feb; 16(1):31-6. PubMed ID: 15897165
[TBL] [Abstract][Full Text] [Related]
7. Treatment of scalp psoriasis with clobetasol-17 propionate 0.05% shampoo: a study on daily clinical practice.
Bovenschen HJ; Van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):439-44. PubMed ID: 19845822
[TBL] [Abstract][Full Text] [Related]
8. Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0·05% combined with ketoconazole shampoo 2%: a randomized, controlled study.
Ortonne JP; Nikkels AF; Reich K; Ponce Olivera RM; Lee JH; Kerrouche N; Sidou F; Faergemann J
Br J Dermatol; 2011 Jul; 165(1):171-6. PubMed ID: 21707573
[TBL] [Abstract][Full Text] [Related]
9. Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial.
Sofen H; Hudson CP; Cook-Bolden FE; Preston N; Colón LE; Colón LE; Caveney SW; Gottschalk RW
J Drugs Dermatol; 2011 Aug; 10(8):885-92. PubMed ID: 21818510
[TBL] [Abstract][Full Text] [Related]
10. Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis.
Tan J; Thomas R; Wang B; Gratton D; Vender R; Kerrouche N; Villemagne H;
Cutis; 2009 Mar; 83(3):157-64. PubMed ID: 19363909
[TBL] [Abstract][Full Text] [Related]
11. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis.
Beutner K; Chakrabarty A; Lemke S; Yu K
J Drugs Dermatol; 2006 Apr; 5(4):357-60. PubMed ID: 16673804
[TBL] [Abstract][Full Text] [Related]
12. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
[TBL] [Abstract][Full Text] [Related]
13. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo.
Shuster S; Meynadier J; Kerl H; Nolting S
Arch Dermatol; 2005 Jan; 141(1):47-52. PubMed ID: 15655141
[TBL] [Abstract][Full Text] [Related]
14. Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study.
Reygagne P; Poncet M; Sidou F; Soto P
Cutis; 2007 May; 79(5):397-403. PubMed ID: 17569404
[TBL] [Abstract][Full Text] [Related]
15. Scalp psoriasis.
Kircik LH; Kumar S
J Drugs Dermatol; 2010 Aug; 9(8 Suppl ODAC Conf Pt 2):s101-5. PubMed ID: 20715392
[TBL] [Abstract][Full Text] [Related]
16. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.
Kimball AB; Gold MH; Zib B; Davis MW;
J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358
[TBL] [Abstract][Full Text] [Related]
17. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
[TBL] [Abstract][Full Text] [Related]
18. Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients.
Sánchez Regaña M; Martín Ezquerra G; Umbert Millet P; Llambí Mateos F
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):573-7. PubMed ID: 16164711
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis.
Jarratt MT; Clark SD; Savin RC; Swinyer LJ; Safley CF; Brodell RT; Yu K
Cutis; 2006 Nov; 78(5):348-54. PubMed ID: 17186795
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Iralfaris shampoo in the treatment of scalp psoriasis: a videodermoscopy evaluation prospective study in 70 patients.
Rossi A; Pranteda G; Iorio A; Mari E; Milani M
G Ital Dermatol Venereol; 2012 Dec; 147(6):625-30. PubMed ID: 23149708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
